William Binning

William Binning

Auto-generated profile, based on publicly available information

William Binning

University of Western Ontario

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 January 2020 in bioRxiv
Verified
Preprint
Open access
PDF file
WBWilliam Binning
William Binning
AHAja E. Hogan-Cann
Aja E. Hogan-Cann
DSDiana Yae Sakae
Diana Yae Sakae
MMMatthew Maksoud
Matthew Maksoud
VOValeriy Ostapchenko
Valeriy Ostapchenko
VPVania Ferreira Prado
Vania Ferreira Prado
Microglia express muscarinic G protein-coupled receptors (GPCRs) that sense cholinergic activity and are activated by acetylcholine to potentially regulate microglial functions. Knowledge about how distinct types of muscarinic GPCR signaling regulate microglia functionin vitroandin vivois still poor, partly due to the fact that some of these receptors are also present in astrocytes and neurons. We generated mice expressing the hM3Dq Designer Receptor Exclusively Activated by Designer Drugs (DREADD) selectively in microglia to investigate the role of muscarinic M3Gq-linked signaling. We show that activation of hM3Dq using clozapine N-oxide (CNO) elevated intracellular calcium levels and increased phagocytosis of FluoSpheresin vitro. Acute treatment with CNOin vivodid not affect male mouse behavior, however chronic CNO treatment decreased sickness behavior triggered by lipopolysaccharide (LPS) treatment. Interestingly, whereas acute treatment with CNO increased synthesis of cytokine mRNA, chronic treatment attenuated LPS-induced cytokine mRNA changes in the brain, likely explaining the improvement in sickness behavior by chronic hM3Dq activation. No effect of CNO was observed in DREADD-negative mice. These results suggest that chronic activation of M3 muscarinic receptors (the hM3Dq progenitor) in microglia, and potentially other Gq-coupled GPCRs, preconditions microglia to decrease their response to further immunological challenges. Our results indicate that hM3Dq can be a useful tool to modulate neuroinflammation and study microglial immunological memoryin vivo, which may be applicable for manipulations of neuroinflammation in neurodegenerative and psychiatric diseases.Highlights: Microglial function was manipulated by specific activation of hM3Dq signaling. Chronic hM3Dq activation prevented LPS-induced sickness behavior in mice. Microglial hM3Dq signaling modulated expression of pro-inflammatory cytokines.